Treatment of rats with the cancer chemopreventive agent l,2-dithiole-3-thlone (D3T) resulted in a significant increase in hepatic heme oxygenase (HO) activity, which corresponded to increased protein levels of HO-1. Upon further analysis of proteins related to heme metabolism, the level of ferritin, the major iron storage protein in liver, was also found to be elevated. Diminished levels of intracellular free iron were monitored by EPR spectroscopy at times after administration of D3T that suggested that increased ferritin content sequesters intracellular iron. The increased levels of protein were associated with increased levels of steadystate RNA of HO-1 and the light (FL) and heavy (FH) subunits of ferritin. A direct relationship between enhanced rates of gene transcription and elevated levels of HO-1 and ferritin RNA was found. The inductions of FL and FH, but not HO-1, were sensitive to cycloheximide, suggesting that in vivo these genes are regulated by distinct D3T-responsive transcriptional mechanisms. The known protective roles for induced HO-1 and ferritin in cellular stress have been suggested to include increased levels of the antioxidant bilirubin and enhanced sequestration of intracellular iron into ferritin, which can effectively reduce iron-mediated reactive oxygen generation. Thus, protective actions of D3T against the cytotoxic and carcinogenic consequences of chemicals that exert electrophilic or oxidative stresses may be mediated, in part, by the induction of HO-1, FL and FH.
Introduction
Dithiolethiones, including 5-(2-pyrazinyl)-4-methyl-l,2-dithiole-3-thione (oltipraz*), anethole dithiolethione and 1,2-dithiole-3-thione (D3T), inhibit experimental tumorigenesis elicited by many structurally diverse carcinogens in numerous target tissues (1) . Because of their high degree of efficacy in inhibiting tumorigenesis, oltipraz and anethole dithiolethione are currently under evaluation as cancer chemopreventive agents in human populations with high risk of exposure to environmental carcinogens (1) . Knowledge of the mechanisms of how these compounds inhibit tumor formation would provide significant insight into the processes of carcinogenesis and anticarcinogenesis. Rigorous analysis of these •Abbreviations: oltipraz, 4-methyl-5-pyrazinyl-3//-1,2-dithiole-3-thione; D3T, 1,2-dithiole-3-thione; HO-1, heme oxygenase-1; FL, ferritin light subunit; FH, ferritin heavy subunit; AFAR, aftatoxin B, aldehyde reductase; ALB, albumin; HO-2, heme oxygenase-2; PBS, phosphate-buffered saline; ARE, antioxidant response element.
chemopreventive actions has shown that they are mediated, in part, by modulation of the metabolism of several classes of carcinogens through inhibition of cytochromes P450 and induction of electrophile detoxification enzymes (1) . Consequently, cellular levels of the ultimate carcinogens and their DNA adducts are reduced. However, additional mechanisms must also be invoked to account for the broad spectrum of anticarcinogenic action of these compounds. In addition to electrophiles, free radicals have been implicated in many aspects of tumorigenesis and, therefore, strategies to reduce free radical and reactive oxygen production have been designed to inhibit tumorigenesis (2) .
Recently, several classes of cancer chemopreventive agents, including the dithiolethiones, were shown to increase the expression of heme oxygenase-1 (HO-1) RNA in mouse hepatoma cells through activation of gene transcription (3) . HO-1 metabolizes the prooxidant heme into the antioxidant bilirubin (4) . Induction of this protein is often associated with increased expression of ferritin (5) . Ferritin, in turn, sequesters ferrous ions, thereby preventing generation of reactive oxygen species via the Fenton reaction (6) . In this report, we demonstrate for the first time that treatment of rats with D3T increases the in vivo hepatic activity of heme oxygenase and elevates protein and RNA levels of HO-1 and ferritin light (FL) and heavy (FH) subunits through transcriptional mechanisms, leading to decreased intracellular free iron concentrations in liver tissues.
Materials and methods

Chemicals and materials
For these studies, D3T and HO-1 cDNA were kindly provided by Dr TJ.Curphey (Dartmouth Medical School) and Dr N.Holbrook (National Institute on Aging, Baltimore, MD) respectively. The FH and FL subunits, aflatoxin B| aldehyde reductase (AFAR) and albumin (ALB) cDNAs were isolated by differential hybridization screening techniques (7) . Goat antihuman ferritin IgG, [a-32 P]dCTP (3000 Ci/mmol) and antibody-horseradish peroxidase and antibody-alkaline phosphatase conjugates were obtained from ICN (Costa Mesa, CA). Purified HO-1, rabbit anti-rat HO-1 and heme oxygenase-2 (HO-2) were purchased from Stressgen (Vancouver, BC).
[a-"P]UTP (3000 Ci/mmol) and [ct- 
Animals and treatments
Male F344 rats (100 g) were obtained from Harlan Sprague-Dawley (Indianapolis, IN) and housed under controlled conditions of temperature, humidity and lighting. Food and water were available ad libitum. Purified diet of the AIN-76A formulation without the recommended addition of 0.02% ethoxyquin was used. Rats were acclimated to this diet for 1 week before beginning the experiments. Rats were treated by gavage with 0.5 mmol/kg D3T given in 200 JJ.1 suspensions consisting of 1% Cremaphor (BASF Wyandotte Inc., Parsippany, NJ) and 25% glycerol in distilled water. Desferrioxamine was dissolved in water and Sn-protoporphyrin Di was dissolved in 0.1 M KOH as a 100-fold stock solution, then neutralized with 0.1 M HC1 and brought up to volume with phosphate-buffered saline (PBS). Desferrioxamine (200 mg/kg i.p.) or Sn-protoporphyrin IX (50 nmol/kg s.c.) was administered 1 h prior to dosing with D3T. Cycloheximide (5 mg/kg i.p.) in sterile PBS was administered 15 min prior to dosing with D3T.
Preparation of S9 fractions
Rat livers were excised and immediately freeze-clamped in liquid nitrogen. Livers were homogenized (20% wet w/v) in 0.1 M Tris-acetate, 0.1 M KCI, 1 mM EDTA, pH 7.4, 0.1 mM phenylmethylsulfonyl fluoride. S9 fractions were prepared by centrifugation of the homogenate for 30 min at 4°C at 9000 g. The supernatant was removed and centrifuged again for 30 min at 4°C at 9000 g. The supernatant (S9) from this second centrifugation was measured for protein content using the bicinchoninic acid protein assay with bovine serum albumin as standard (Pierce Inc., Rockford, IL).
Heme oxygenase activity
The heme oxygenase activity in S9 fractions was determined according to the method of Yoshinaga et aL (8) . Bilirubin production from the metabolism of heme was determined from the absorbance at 468 nm normalized to that at 520 nm. Enzymatic rates were calculated from the absorbance using an extinction coefficient of 43.5/mM/cm at 468 nm.
SDS-PAGE and immunoblot analysis
Liver S9 protein preparations (80 ng/lane) were separated on 12.5% SDS-PAGE gels and immunoblots were developed by standard methods. Rat liver ferntin purified according to the method of Powell et al. (9) and purified HO-1 (Stressgen) were used as positive controls for the ferritin and HO immunoblots respectively. Immunoblots were developed using goat anti-human liver FL IgG (1/50), rabbit anti-rat HO-1 (1/1000) or rabbit anti-rat HO-2 (1/1000) and goat anti-rabbit alkaline phosphatase (1/2000) coupled with the bischloroindolyl phosphate/nitroblue tetrazolium substrate system. Densitometric areas for HO-1, HO-2 or the FL subunit were obtained using an Epson scanner at a resolution of 6000 d.p.i. and the data analyzed by MacBAS v2.0 quantitation software (Fuji Inc., Stamford, CT).
EPR determination of free iron content
Redox active iron, also termed free iron, was measured by EPR spectroscopy using desfernoxamine as chelating agent as described by Cairo et al. (5) . Briefly, 0.05 ml 10 mM desferrioxamine was added to 0.5 ml liver homogenate (50* w/v in chelated PBS), which, after incubation at room temperature for 10 min, was placed in a cylindrical quartz tube, frozen and stored in liquid nitrogen. EPR spectra were recorded at 77 K on an IBM-Bruker (model ER-300) instrument operating in the X-band with a TM-110 cavity under the following instrumental conditions: modulation frequency, 100 kHz; modulation amplitude, 5.0 G; scan time, 60 s; receiver gain, 1X10 3 ; microwave power, 39 mW; microwave frequency, 9.3 GHz. The intensity of the EPR signal at g = 4.3 was measured to estimate desferrioxamine-iron concentrations. Free iron concentrations in homogenates were calculated from a calibration curve generated using 0.01-0.1 mM FeCl 3 in 1 mM desferrioxamine to relate EPR signal intensity to chelated iron concentrations.
RNA blot and nuclear run-on analyses
Total RNA isolation and RNA blot analysis were performed according to established procedures. Levels of RNA were quantitated using a Fuji BAS 1000 phosphonmaging system by correcting for local background and normalizing for RNA loading by stripping and reprobing the blots with a cDNA probe for ALB. In all cases, signals above background were detectable by phosphorimaging analysis. Nuclear run-on assays were performed as previously described (7, 10) . Livers from rats treated with D3T or vehicle were obtained 6 and 18 h after treatment Nuclei were isolated from 5 g tissue. Nuclear RNA was isolated from the nuclei as previously described (7).
Results
Liver S9 fractions from rats 6 h after treatment with vehicle or D3T were isolated. Heme oxygenase activity associated with this subcellular fraction was induced 1.7-fold from 0.23 ± 0.01 to 0.39 ± 0.06 nmol bilirubin formed/min/mg protein. Since total activity of heme oxygenase is the sum of at least two enzymes, HO-1 and HO-2, immunoblot analysis of the liver S9 fractions from vehicle-and D3T-treated rats was performed. The levels of HO-1 protein were dramatically elevated over those of untreated controls at 6 h following treatment with D3T ( Figure 1A , lanes 5-7 versus 2-4). HO-1 protein levels remained elevated up to 24 h after treatment with D3T ( Figure 1A, lanes 11-13) . The levels of HO-2 protein failed to increase in response to administration of D3T ( Figure IB 1 and 14) ; hepatic cytosol from rats treated with vehicle at 6 h (lanes 2-4), D3T at 6 h (lanes 5-7), vehicle at 24 h (lanes 8-10) or D3T at 24 h (lanes 11-13) using (A) rabbit anti-rat HO-1, (B) rabbit anti-rat HO-2 or (C) rabbit antirat FL.
to the observed formation of bilirubin, the calculated level of induction of HO-1 by activity measurements was underestimated.
Since increased heme oxygenase activity has been associated with an increase in intracellular ferritin, the level of ferritin protein was determined. An immunoreactive band representing rat ferritin, presumably FL, with an M T of ~20 000 was detected in S9 fractions from vehicle-and D3T-treated rats ( Figure 1C ). The corresponding levels of the protein band were elevated 3.7-and 5.0-fold respectively in the hepatic S9 fractions of rats 6 and 24 h after treatment with D3T ( Figure 1C ). These results suggest that ferritin and heme oxygenase were coinduced in rat liver by administration of D3T.
To investigate the effects of increased ferritin content on the intracellular levels of free iron, measurements of iron were made using EPR spectroscopy. Iron-desferrioxamine concentrations in rat liver homogenate were measured at 6, 18, 24, 30, 36 and 48 h after dosing rats with D3T. A typical first derivative of the iron-desferrioxamine spectrum is shown in Figure 2A for the homogenate prepared from rats 24 h after dosing with vehicle control or D3T. A time-dependent decrease in intracellular desferrioxamine-iron chelate was monitored between 18 and 30 h, with a maximum decrease of -40% 24 h after a single dose of D3T ( Figure 2B ). These results suggest that intracellular free iron decreases concordantly with increased ferritin levels between 18 and 30 h.
In order to determine whether increases in HO-1 and ferritin occur as the result of transcriptional mechanisms, levels of RNA and rates of gene transcription were measured. Northern blot analysis revealed that HO-1 RNA was constitutively expressed at very low levels and was increased >9-fold over the control by 6 h after dosing with D3T ( Figure 3) . HO-1 RNA levels diminished to control levels by 24 h, indicating a transient induction. Levels of FL and FH RNAs were constitutively expressed at very high levels and were increased >3-and 2-fold respectively by 6 h after administration of D3T ( Figure 3A) . The levels of the FL and FH RNA remained increased, by 5-and 2-fold respectively, as long as 24 h after treatment ( Figure 3B ). In our study, the inductions of HO-1 and ferritin were compared with those of AFAR, a representative carcinogen detoxification enzyme, which is highly induced by D3T and oltipraz (7, 11) . The apparent distinction of AFAR from those proteins involved in iron metabolism rendered it a suitable positive control for these studies. The constitutive levels of AFAR RNA were very low and were induced 35-and 24-fold by 6 and 24 h following dosing respectively. 1550
Magnetic Field (Gauss) As previously shown (12), heme oxygenase-catalyzed release of iron from intracellular heme stores could explain the observed increase in ferritin protein. However, treatment with the iron chelator desferrioxamine by a protocol known to inhibit the induction of ferritin in response to hydrogen peroxide, UV irradiation or iron administration (12) failed to block the induction of FL, FH or AFAR by D3T at 6 or 24 h after dosing ( Figure 3A and B, lanes 7-9 respectively). Similarly, Sn-protoporphyrin DC, an inhibitor of heme oxygenase activity, did not affect the induction of FL, FH or AFAR, indicting that a novel heme oxygenase-independent increase in ferritin transcription occurs in response to D3T at 6 and 24 h after dosing ( Figure 3A and B, lanes 10-12 respectively). This result indicates that the mechanism of ferritin induction by D3T is independent of intracellular iron concentration.
In order to determine whether increased RNA levels resulted from transcriptional activation of these genes, nuclear run-on analyses were performed at 6 and 18 h following D3T treatment (Figure 4) . Transcription rates were measured at a time point (18 h) before the maximum level of steady-state RNA (24 h) was reached. The rates of transcription for HO-1, FL, FH and AFAR genes increased 21-, 10-, 5-and 50-fold respectively at 6 h after administration D3T. The rates of transcription of FL and AFAR remained elevated after 18 h, albeit at lower levels than at 6 h (5-and 17-fold respectively over control); while the rate of transcription of HO-1 and FH returned to control levels.
Cycloheximide was used to determine whether de novo protein synthesis was a prerequisite of the inductive effects of D3T, as shown in Figure 5 . Interestingly, gene-specific differences were observed. In contrast to FL, FH and AFAR, which were sensitive to a 15 min pretreatment with cycloheximide, the levels of HO-1 RNA were further enhanced. These results suggested that FL, FH and AFAR, but not HO-1, required the synthesis of a protein(s) as part of their transcriptional response to D3T
Discussion
The dithiolethiones are a particularly active class of cancer chemopreventive agents whose action has been largely associated with the induction of carcinogen detoxification enzymes, including quinone reductase, epoxide hydrolase, UDP-glucuronosyltransferases, glutathione S-transferases and AFAR (1, 13) . Induction of these enzymes facilitates the metabolic clearance of chemical carcinogens and results in markedly reduced levels of carcinogen-DNA adducts in target tissues (13) . The broad cancer chemopreventive efficacy of dithiolethiones indicates that multiple mechanisms may contribute to their protective effects.
In this report, we have demonstrated that the induction of heme oxygenase and ferritin by D3T was the result of enhanced rates of gene transcription. The identification of HO-1, FL and FH as a subset of genes that are activated in response to D3T suggests an important additional mechanism for cancer chemoprevention. HO-1 metabolizes the pro-oxidant heme, producing free iron, carbon monoxide and biliverdin. Biliverdin is converted rapidly to the antioxidant bilirubin (4) . Bilirubin has been demonstrated to act as an antioxidant by its inhibition of lipid peroxidation in vitro. Reduction of lipid peroxidation has been associated with increased survival of cells following oxidative stress generated by certain xenobiotics (14) . Hence, elevation of HO-1 activity may contribute to the chemopreventive effects of dithiolethiones.
Ferritin acts as a natural iron chelator to limit the reactivity of heme-derived intracellular iron (15) . Evidence supporting this hypothesis includes results from cultures of fibroblasts in which pre-exposure to UVA irradiation or hemin resulted in a heme oxygenase-dependent induction of ferritin synthesis. This increase in the amount of ferritin was sufficient to inhibit oxidative damage caused by subsequent UVA irradiation (12, 16) . Ferritin, whether endogenously produced or added directly as the apoprotein, protected cells from oxidantmediated cytolysis in a concentration-dependent manner. By expression of a recombinant mutant of FH, Balla and coworkers (6) demonstrated the critical role of the ferroxidase and iron sequestering properties of ferritin in this cytoprotection. Within most cells the major depot of non-metabolic iron is ferritin, a multimeric (24 subunit) protein (H chain M t 21 000 or L chain M t 20 700 in humans) with a total molecular weight of 450 kDa that has a very high capacity for storing 123456789 101112 Fig. 3 . Analysis of RNA levels by RNA blot hybridization following D3T treatment Shown are representative RNA blots of total RNA isolated from liver of rats at 6 (A) and 24 h (B) after treatment. Rats were administered vehicle control (lanes I-3), D3T (lanes 4-6), D3T and desferrioxamine (DES, lanes 7-9) or D3T and Sn-protoporphyrin LX (SPP, lanes 10-12). The blots were hybridized using cDNA probes for FL, FH, HO-1, AFAR or ALB as a standard for loading. Radioactive signals from hybridized blots were quantified as described in Materials and methods. Results are expressed as the mean fold increase (± SD).
iron (4500 mol iron/mol ferritin). It has been proposed that there is a small intracellular pool of free iron that can react with reactive oxygen species generated endogenously to produce the very reactive hydroxyl radical, which in turn initiates lipid peroxidation, protein oxidation and DNA damage (14) . Furthermore, iron administration that results in the preferential production of FL-rich forms of ferritin may provide an enhanced and prolonged capacity for iron storage (17, 18) . Accordingly, the 5-fold induction of FL subunit protein, as observed 24 h after treatment with D3T, results in increased sequestration of iron, as evidenced by a >40% reduction in intracellular free iron chelated to desferrioxamine and detected by EPR spectroscopy. The decreased intracellular iron that was observed between 18 and 30 h after dosing with D3T is coincident with increased levels of ferritin protein and follows the time course of ferritin mRNA induction after a single dose of D3T (7). The diminished levels of free iron are putatively the result of sequestration of ferrous ion by ferritin, a consequence of which would be the prevention of reactive oxygen Figure 2 . Results are the average fold increase (± SD) from three separate rats. Differences in the means for each treatment group were determined by one way ANOVA and Bonferroni's multiple comparison test. Single asterisks denote significant differences (P < 0.05) between groups treated with D3T versus vehicle. Double asterisks denote significant differences (P < 0.05) between groups treated with cycloheximide and D3T from those receiving D3T alone.
production via the Fenton reaction, hence protecting the cell from the formation of oxidized biomolecular products. Induction of ferritin protein by a post-transcriptional elevation of ferritin translation by increased concentrations of intracellular iron has been well documented (21) (22) (23) (24) . To date, iron administration or treatments leading to increased intracellular iron have been demonstrated to activate transcription of the FL gene (5, 21) . The results presented here indicate that D3T can transcriptionally activate FL by a mechanism apparently independent of the intracellular level of iron. Therefore, induction of the FL and FH genes by D3T points to possible additional mechanisms of regulation of these genes. Previous studies have shown that D3T activates the mouse glutathione S-transferase Ya and HO-1 genes (3, 19) . Two consensus antioxidant response element (ARE) sequences, 5'-TGACnnnGC-3', which are known to be critical for the DNA binding and transcriptional activity associated with the ARE, are found in the upstream regions of the mouse glutathione Stransferase and HO-1 genes (3). Cloning of these elements into a reporter construct and transfection into mouse hepatoma cells was sufficient to mediate the enhanced transcription elicited by various inducers, including D3T (3). The results reported here are consistent with a similar mechanism for the induction of HO-1 in rat liver by D3T. Since FL is transcriptionally activated along with HO-1 following treatment with D3T and since two ARE-like sequences were found upon inspection of the reported rat FL gene (20) , we propose that D3T activates the FL gene through an ARE. The implications for multiple mechanisms of enhancement of ferritin gene expression are witnessed in the differential expression of ferritin subunit genes by growth factors and cytokines. Tumor necrosis factor-a, interleukin-la (25, 26) and thyrotropin and cAMP (27, 28) activate the FH, but not FL, gene by transcriptional mechanisms; a result that suggests that modulation of ferritin composition and iron storage may be an important cellular response to a variety of physiological stimuli.
HO-1 induction following administration of D3T was not inhibited by cycloheximide, as was FL, FH, and AFAR. In fact, cycloheximide appears to superinduce the levels of HO-1 mRNA. Cycloheximide has been shown to superinduce a number of cell cycle-related genes, including ornithine decarboxylase, c-fos and c-myc, following stimulation with mitogens such as fibroblast growth factor or epidermal growth factor (29) (30) (31) . Superinduciblity of these genes has been attributed to inhibition of the synthesis of a labile repressor protein that disappears in the absence of protein synthesis (29) or to prolonged transcription and stabilization of mRNAs (30, 31) . The interpretation that a repressor is involved in regulation of the HO-1 gene is supported by its low constitutive level of expression. A repressor protein may also be postulated for the low constitutive level of expression of the AFAR gene, however, this hypothetical repressor protein is not sensitive to cycloheximide. These observed differential responses of the studied genes to cycloheximide underscore the separate mechanisms governing regulation of HO-1 and FL and FH and AFAR. Superinducibility of HO-1 by prolonged transcription and stability of mRNA may play a role in the increased expression of HO-1 mRNA after treatment with D3T and cycloheximide and warrants further study. In summary, dithiolethiones appear to activate multiple protective pathways which serve to enhance their effectiveness as cancer chemopreventive compounds. The observed induction of HO-1, FL and FH expands the families of genes affected by dithiolethiones. Transcriptional activation of these genes may be important components of the cancer chemopreventive effects of dithiolethiones. Treatment of rats with D3T results in diminished levels of intracellular free iron in liver, possibly by sequestration of iron by increased ferritin protein. In addition to modifying carcinogen metabolism, dithiolethiones may inhibit carcinogenesis through increased synthesis of HO-1 and ferritin, resulting in enhanced antioxidant protection and diminished production of reactive oxygen species through lowered intracellular iron levels.
